<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02885675</url>
  </required_header>
  <id_info>
    <org_study_id>ARDS miRNA</org_study_id>
    <nct_id>NCT02885675</nct_id>
  </id_info>
  <brief_title>An Observational Study of the Correlation Between miRNA in Peripheral Blood and Prognosis in Patients With ARDS</brief_title>
  <official_title>An Observational Study of the Correlation Between miRNA in Peripheral Blood and Prognosis in Patients With ARDS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southeast University, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southeast University, China</source>
  <brief_summary>
    <textblock>
      To evaluate the correlation between the value of miRNA related to ARDS and vascular
      endothelial cell and ARDS severity, vascular endothelial cell damaging degree，mortality in
      patients with ARDS.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After consulting literature, we obtain 14 miRNAs related to ARDS and vascular endothelial
      cell(ARDS-VEC-miRNAs) and 2 biomarkers of scathing vascular endothelial.The ARDS-VEC-miRNAs
      include
      miR-15a-5p,miR-16-5p,miR-21-5p,miR-24-3p,miR-26a-5p,miR-27a-3p,miR-27b-3p,miR-126-3p,miR-150-
      5p,miR-146a-5p,miR-155-5p,miR-221-3p,miR-223-3p,miR-320a.The biomarkers of scathing vascular
      endothelial include vascular cell adhesion molecule-1(VCAM-1),von Willebrand factor(vWF).20
      healthy controls and 60 patients diagnose as ARDS in ICU were included in this study.we blood
      every participants within 24 hours after enrollment and obtain the plasma.Then, we detecte
      ARDS-VEC-miRNAs,VCAM-1,vWF levels in plasma by real-time quantitative PCR,record the severity
      of the illness and survival status within 28 days of every patients.Finally,we evaluate the
      correlation between the value of miRNA related to ARDS and vascular endothelial cell and ARDS
      severity, vascular endothelial cell damaging degree，mortality in patients with ARDS.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">February 2017</completion_date>
  <primary_completion_date type="Anticipated">February 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>28-day</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>ARDS</condition>
  <arm_group>
    <arm_group_label>ARDS</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy control</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood sampling</intervention_name>
    <description>sample no more than 3ml</description>
    <arm_group_label>ARDS</arm_group_label>
    <arm_group_label>Healthy control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        20 healthy controls and 60 patients diagnose as ARDS in ICU were included in this study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:(1)Admitted to ICU, ARDS patients(Berlin criteria), (2)Patients
        diagnosed ARDS within 24 hours, (3)Patients age between 18 years old and 85 years.

        Exclusion Criteria:1)Pregnant women, 2)Patients with malignant tumor, 3)Immunosuppression
        or immunocompromised patients.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hunag Yingzi, doctor</last_name>
    <phone>+8613951693278</phone>
    <email>yz_huang@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zhong-Da hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210009</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huang Yingzi, doctor</last_name>
      <phone>+8613951693278</phone>
    </contact>
    <investigator>
      <last_name>Zheng Yi, postgraduate</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 25, 2016</study_first_submitted>
  <study_first_submitted_qc>August 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2016</study_first_posted>
  <last_update_submitted>August 30, 2016</last_update_submitted>
  <last_update_submitted_qc>August 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 31, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Southeast University, China</investigator_affiliation>
    <investigator_full_name>Jianfeng Xie</investigator_full_name>
    <investigator_title>Zhongda Hospital</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

